-
Sodium Ascorbate in Translational Oncology
2026-09-21
Sodium Ascorbate is more than a vitamin C derivative in oncology research: it is a controllable redox perturbation for studying tumor-cell injury, invasion, and treatment response. This article connects ROS-driven necrotic death in glioblastoma models with emerging immune-biomarker research while defining the evidence boundaries for translational investigators.
-
Ouabain (B2270) for Reliable Cell Assays
2026-09-20
This scenario-driven guide explains how Ouabain (SKU B2270) can improve the design and interpretation of Na⁺/K⁺-ATPase inhibition assays, cell viability studies, and cardiovascular research workflows. It connects mechanism, dose selection, vendor evaluation, and translational limitations to practical laboratory decisions.
-
AMD-070 Hydrochloride: CXCR4 Assay Workflows
2026-09-19
Build more informative migration, signaling, and combination assays with AMD-070 hydrochloride, a selective small-molecule CXCR4 antagonist. This workflow connects CXCR4 genotype, CXCL12-dependent phenotypes, and translational assay controls while clearly separating research observations from clinical interpretation.
-
AMPK–JAK2/STAT3 Signaling in Obesity-Related Asthma
2026-09-18
The reference study identifies reduced AMPK activity and M1 macrophage polarization as linked features of obesity-related asthma, and connects this inflammatory phenotype to JAK2/STAT3 signaling. Its combined mouse and RAW264.7-cell design supports AMPK as a mechanistic regulator of airway inflammation while also highlighting the need for careful validation beyond experimental models.
-
GS-441524 Applied Research Workflows
2026-09-18
Build more informative antiviral assays by separating GS-441524 exposure, prodrug conversion, and intracellular activation. This practical guide combines solvent handling, LC–MS/MS sampling, pharmacokinetic study design, and troubleshooting for reproducible SARS-CoV-2 research.
-
AICAR Assay Workflows and Reliability
2026-09-17
A practical, scenario-based guide to using AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside), SKU A8184, in viability, proliferation, cytotoxicity, metabolism, and inflammation experiments. It connects formulation data, pathway controls, handling parameters, and literature-based interpretation to improve reproducibility without confusing metabolic effects with cell loss.
-
Paroxetine in Colon Cancer: MET and ERBB3
2026-09-16
The reference study identified paroxetine, a Selective serotonin reuptake inhibitor, as a repurposing candidate for colorectal cancer and linked its activity to MET and ERBB3 signaling. Across HCT116 and HT-29 models, paroxetine reduced viability, clonogenic growth, and spheroid formation, increased apoptosis, and suppressed HT-29 xenograft growth, while pathway experiments implicated AKT, ERK, p38, JNK, and caspase-3.
-
Triiodothyronine (T3) for Adipocyte Assays
2026-09-16
Use Triiodothyronine (T3) as a controlled endocrine input for adipocyte differentiation, thermogenesis, and cellular metabolism assays. This workflow separates thyroid hormone receptor activation from SEMA3E–β-catenin signaling, helping researchers build more interpretable metabolic disorder models.
-
3-Deazaneplanocin (DZNep) Workflow Guide
2026-09-15
3-Deazaneplanocin (DZNep) links S-adenosylhomocysteine hydrolase inhibition with EZH2-associated epigenetic remodeling, making it useful for mechanism-led cancer and metabolic disease assays. This guide translates that activity into practical workflows for apoptosis induction in AML cells, cancer stem cell targeting, and hepatocellular carcinoma research, with built-in controls and troubleshooting steps.
-
GKT137831: A Redox-to-Ferroptosis Assay Framework
2026-09-15
GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, offers a rigorous way to connect ROS generation with plasma-membrane failure. This article translates recent ferroptosis findings into practical assay design for vascular, fibrotic, and oxidative-stress research.
-
Tetrazolium Red: From Viability Signal to Translation
2026-09-14
Tetrazolium (chloride), also known as Tetrazolium Red or TTC, is more than a colorimetric reagent: it is a functional bridge between mitochondrial redox activity, tissue viability, and translational decision-making. This article places TTC staining in the mechanistic context of oxidative injury and cardamomin-mediated protection in cerebral ischemia, while outlining practical strategies for producing more decision-ready data.
-
CUX2 Neuron Loss from DNA Damage in Neuroinflammation
2026-09-14
The reference study identifies accumulated DNA damage and inadequate double-strand break repair as drivers of selective CUX2-positive layer 2/3 excitatory neuron loss during neuroinflammation. By integrating human multiple sclerosis tissue, mouse models, genetic analyses, and interferon-γ exposure, it connects neuronal subtype vulnerability to CUX2, ATF4, reactive oxygen species, and DNA repair capacity.
-
EdU Flow Cytometry Assay Kits (Cy5) Workflow
2026-09-13
EdU Flow Cytometry Assay Kits (Cy5) provide a denaturation-free way to quantify DNA synthesis during S phase using EdU incorporation and Cy5 click-chemistry detection. They are intended for research flow cytometry workflows, including proliferation, genotoxicity, and pharmacodynamic studies, rather than clinical diagnostics, in vivo labeling, or tissue imaging.
-
GS-441524: A Matrix-Aware Assay Strategy
2026-09-12
GS-441524 research is most informative when parent compound, prodrug, and active metabolite are measured as distinct analytical entities. This matrix-aware guide translates recent LC–MS/MS findings into practical decisions for antiviral assays and pharmacokinetic studies.
-
GS-441524: From Nucleoside to Translational Strategy
2026-09-11
GS-441524 is more than a single antiviral test article: it is a platform for studying nucleoside activation, prodrug conversion, matrix-specific exposure, and translational pharmacokinetics. New LC–MS/MS findings on the NGP-1 GS-441524 prodrug show why researchers should measure parent and metabolite together rather than infer biological performance from nominal dosing alone.